BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Jul 15, 2026; 18(7): 120437
Published online Jul 15, 2026. doi: 10.4251/wjgo.120437
Table 1 Baseline characteristic comparison (development vs temporally independent test cohort), mean ± SD/n (%)
Characteristics
Development cohort (n = 680)
Independent test cohort (n = 170)
Statistic
P value
Age (years)62.56 ± 10.7063.24 ± 11.440.9180.359
Sex (male/female)375/30595/750.0300.863
BMI (kg/m2)23.5 ± 3.223.8 ± 3.4t = 1.060.291
Ileus0.8030.370
Yes68 (10.0)21 (12.4)
No612 (90.0)149 (87.6)
Tumor location
Colon cancer425 (62.5)105 (61.8)χ2 test0.861
Rectal cancer255 (37.5)65 (38.2)
Maximum tumor diameter (cm)4.2 ± 1.84.3 ± 1.7t-test0.512
Preoperative CEA (≥ 5 ng/mL)306 (45.0)77 (45.3)0.0050.945
T-staging
T185 (12.5)22 (12.9)0.0510.997
T2170 (25.0)43 (25.3)
T3306 (45.0)75 (44.1)
T4119 (17.5)30 (17.6)
N-staging
N0374 (55.0)93 (54.7)0.0200.995
N1204 (30.0)51 (30.0)
N2102 (15.0)26 (15.3)
Pathological differentiation0.2030.652
High/moderate differentiation476 (70.0)122 (71.8)
Poor differentiation/mucinous adenocarcinoma204 (30.0)48 (28.2)
Image quality score
3 points (acceptable)204 (30.0)51 (30.0)0.0001.000
4 points (good)340 (50.0)85 (50.0)
5 points (excellent)136 (20.0)34 (20.0)


Write to the Help Desk